Risk-Adapted Adjuvant Chemotherapy After Concomitant Fluoropyrimidine–Radiotherapy Neoadjuvant Treatment for Patients With Resectable CT3-4 or N+ Rectal Cancer: Five-Year Disease-Free Survival Results of a Single-Center Series
Titel:
Risk-Adapted Adjuvant Chemotherapy After Concomitant Fluoropyrimidine–Radiotherapy Neoadjuvant Treatment for Patients With Resectable CT3-4 or N+ Rectal Cancer: Five-Year Disease-Free Survival Results of a Single-Center Series
Auteur:
Sastre, Javier Serrano, Juan Jose Fernández, Cristina Ramirez, Carmen Ortega, Luis García-Paredes, Beatriz Corona, Juan Alfonso, Rosario Córdoba, Sofía Díaz-Rubio, Eduardo